Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gerna

Showing results (161-170 of 179) with videos related to

Pageof 18
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 18, 2000
Higher short-term virologic efficacy of three-class versus two-class highly active antiretroviral salvage therapy in HIV-infected patientsF Baldanti, S Paolucci, R Maserati, et al.
Journal of Neurovirology|April 8, 1998
Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. European Union Concerted Action on Virus Meningitis and EncephalitisP Cinque, G M Cleator, T Weber, et al.
Antiviral Research|June 9, 2001
Higher levels of HIV DNA in memory and naive CD4(+) T cell subsets of viremic compared to non-viremic patients after 18 and 24 months of HAARTF Baldanti, S Paolucci, R Gulminetti, et al.
International Journal of Cancer|January 15, 1987
Association of BK virus with human brain tumors and tumors of pancreatic isletsA Corallini, M Pagnani, P Viadana, et al.
The New Microbiologica|November 11, 1999
Diagnostic value of viral culture, polymerase chain reaction and western blot for HIV-1 infection in 218 infants born to HIV-infected mothers and examined at different agesE Cattaneo, M Zavattoni, F Baldanti, et al.
Journal of Clinical Microbiology|June 1, 1990
Serotype 3 human rotavirus strains with subgroup I specificityG Gerna, A Sarasini, A Di Matteo, et al.
British Journal of Haematology|December 22, 1999
The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disordersM Lazzarino, E Orlandi, F Baldanti, et al.
Journal of Virology|January 9, 1999
Polo-like kinase 1 as a target for human cytomegalovirus pp65 lower matrix proteinA Gallina, L Simoncini, S Garbelli, et al.
The Journal of Infectious Diseases|March 1, 1989
Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccineC F Lanata, R E Black, R del Aguila, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 5, 2011
Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal bloodE Fabbri, M G Revello, M Furione, et al.
Pageof 18

Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 18, 2000
Higher short-term virologic efficacy of three-class versus two-class highly active antiretroviral salvage therapy in HIV-infected patientsF Baldanti, S Paolucci, R Maserati, et al.
Journal of Neurovirology|April 8, 1998
Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. European Union Concerted Action on Virus Meningitis and EncephalitisP Cinque, G M Cleator, T Weber, et al.
Antiviral Research|June 9, 2001
Higher levels of HIV DNA in memory and naive CD4(+) T cell subsets of viremic compared to non-viremic patients after 18 and 24 months of HAARTF Baldanti, S Paolucci, R Gulminetti, et al.
International Journal of Cancer|January 15, 1987
Association of BK virus with human brain tumors and tumors of pancreatic isletsA Corallini, M Pagnani, P Viadana, et al.
The New Microbiologica|November 11, 1999
Diagnostic value of viral culture, polymerase chain reaction and western blot for HIV-1 infection in 218 infants born to HIV-infected mothers and examined at different agesE Cattaneo, M Zavattoni, F Baldanti, et al.
Journal of Clinical Microbiology|June 1, 1990
Serotype 3 human rotavirus strains with subgroup I specificityG Gerna, A Sarasini, A Di Matteo, et al.
British Journal of Haematology|December 22, 1999
The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disordersM Lazzarino, E Orlandi, F Baldanti, et al.
Journal of Virology|January 9, 1999
Polo-like kinase 1 as a target for human cytomegalovirus pp65 lower matrix proteinA Gallina, L Simoncini, S Garbelli, et al.
The Journal of Infectious Diseases|March 1, 1989
Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccineC F Lanata, R E Black, R del Aguila, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 5, 2011
Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal bloodE Fabbri, M G Revello, M Furione, et al.
Pageof 18